Honasa Consumer Ltd. account plan
Creating digital-first consumer brands
At a glance
Honasa Consumer, owner of Mamaearth and The Derma Co, reported FY 25-26 like-for-like revenue of ₹24,785 Mn and EBITDA of ₹2,312 Mn.
Honasa Consumer Limited (NSE and BSE: HONASA) describes itself as a digital-first beauty and personal care company and runs a House of Brands: Mamaearth, The Derma Co, Aqualogica, Dr. Sheth's, BBLUNT, Staze 9to9 and Reginald Men, across skincare, haircare, baby care and colour cosmetics. It sells in India through online channels (68% of revenue) and offline (32%). Mamaearth is the founding brand. In FY 25-26 (year to 31 March 2026) it reported like-for-like revenue from operations of ₹24,785 Mn, up 19.9%, and profit after tax of ₹2,002 Mn, with about 3,400 employees. It is listed and independent, led by co-founders Varun Alagh (Chairman and CEO) and Ghazal Alagh (Chief Innovation Officer).
Business units
Mamaearth
The founding brand: toxin-free skincare, haircare, baby care and colour care made with natural ingredients. It returned to teens growth in FY 25-26, with Rice Face Wash joining Ubtan and Vitamin C face washes in the ₹100 Crores net sales club. NielsenIQ puts its offline value share at 6.5% in face cleansers and 2.3% in shampoo as of March 2026.
The Derma Co
₹750 Cr annual recurring revenue run rateScience-backed actives skincare launched in February 2020, with a double-digit EBITDA profile. Sunscreen, serums and face cleansers are each above ₹100 Cr, and it entered haircare in FY 25-26. Offline expansion reached ₹100 Cr ARR.
Aqualogica
Hydration-led skincare for Gen Z, spanning sunscreens, moisturisers, cleansers and body mists. It launched a sunscreen with India's first Anti-Pollution Factor and refreshed its packaging. The report's milestones page lists it, with Dr. Sheth's, as having crossed ₹200 Cr ARR.
BBLUNT
Professional-style haircare, styling, hair colour and tools for use at home. It relaunched its hair colour portfolio and added a BBLUNT x Tarini styling range; BBLUNT Salons support the brand.
Dr. Sheth's
Skincare for Indian skin from three generations of skin specialists, covering sunscreens, moisturisers, serums and face cleansers. It moved into prestige actives such as Argireline, PDRN and Copper Peptides, and management says its proposition is under review.
Staze 9to9
Long-wear colour cosmetics for Gen Z on C-Lock Technology, across lip, eye and face. Gloss Lock 2-in-1 Liquid Lipstick is named as a strong performer.
Reginald Men
₹100+ Cr annual recurring revenue run rateMen's personal care brand, with a sunscreen-led range and most sales in South India, acquired in January 2026 (95% of BTM Ventures Private Limited). Revenue doubled year on year in its first full quarter of consolidation, making it the sixth Honasa brand above ₹100 Cr ARR.
Fang (minority investment)
25% stakeHonasa took a 25% stake in Couch Commerce Private Limited, which runs the prestige oral care brand Fang Oral, in December 2025. It marks Honasa's entry into oral beauty.
Strategic priorities
- Seven focus categories
- Face cleansers, shampoos, sunscreens, moisturisers, face serums, lipsticks and baby care now contribute about 80% of revenue and grew about 30% in FY 25-26. Close to 90% of brand investment goes to them.
- FY 30-31 vision
- The report targets becoming the fastest FMCG company in India to ₹5,500+ Cr revenue, Mamaearth at ₹2,000+ Cr, The Derma Co beyond ₹1,500 Cr, and a 15% EBITDA margin (500 bps more).
- Direct general trade distribution
- Direct distribution now handles close to 80% of general trade billing, up from roughly a third two years earlier, with about 1.2 lakh outlets billed directly and total reach of 2.7 lakh+ FMCG outlets.
- Quick commerce and omnichannel
- Quick commerce is about 10% of revenue and the fastest-growing channel. Modern trade reaches 10,000+ stores across 30+ chains.
- AI across the business
- Agent OS runs 30+ AI agents across 6 business functions, alongside Tesseract for consumer simulation, FormulaOS for formulation and Creative OS for content.
- New brands and next-horizon categories
- New brands are built to be contribution-margin neutral by year two. Nutraceuticals, fragrances and oral care are named as next-horizon categories.
Latest results
In Q2 FY27 (quarter ended 30 September 2026), consolidated revenue from operations was ₹7,311.87 million versus ₹5,380.63 million in Q2 FY26, and profit after tax was ₹732.48 million versus ₹392.27 million. For the six months, revenue was ₹14,871.33 million versus ₹11,333.17 million. On the 6 November 2026 call, Varun Alagh said net sales grew 36%, EBITDA doubled and the EBITDA profile was 12.7%, calling it the highest growth quarter since listing. Focus categories grew 40%+ and Mamaearth kept high-teens growth. He called the 150 to 200 bps margin plan conservative and expects H2 margins around 12.5%.
Investments and deals
- Reginald Men acquisition
- 95% of BTM Ventures Private Limited acquired, completed on 6 January 2026. The brand recorded revenue above ₹700 million at about 25% EBITDA margin in the twelve months to October 2025.
- Fang minority stake
- 25% of Couch Commerce Private Limited (Fang Oral), completed on 15 December 2025.
- Honasa Health
- Wholly owned subsidiary incorporated on 7 July 2026 to run B2C nutraceuticals.
- Fluence Pharma deal called off
- A proposed 58% acquisition of Fluence Pharma Private Limited was called off on 25 August 2026 because closing conditions were not met.
- First dividend
- ₹3.00 per share, about ₹978.07 million, roughly 51.2% of standalone net profit after tax, approved at the AGM on 28 September 2026.
Challenges and risks
- Macro and energy-cost volatility
- The report names Middle East tensions lifting energy, freight and packaging costs, mitigated by calibrated pricing and sourcing diversification.
- Offline credit and inventory
- The offline network carries credit exposure to channel partners, and inventories rose to ₹2,319.94 million at 30 September 2026 from ₹1,650.51 million at 31 March 2026.
- Consumer preference and brand investment returns
- The company lists the risk of failing to follow evolving beauty trends and marketing campaigns not delivering the intended return.
- Data privacy and counterfeiting
- The company processes significant customer data under the Digital Personal Data Protection Act, 2023 (compliance timeline up to 2027), and its brands face counterfeiting and look-alike products.
- Supply chain disruption
- Dependency on suppliers and logistics partners could affect product availability across a 12-warehouse network.
What leadership says
“Quarter 2 FY '27 is the highest growth quarter since we went public, across the last 12 quarters.”
“Reinvention has earned us this resilience. The next five years are about what we do with it.”
“being conservative is likely the wiser stance”
Where a supplier can help
- Distribution and field-force technology
- Tied to the direct distribution rebuild (about 1.2 lakh outlets billed directly) and the offline credit and inventory risk: distributor management, sales-force automation, retail execution and receivables tools.
- AI, data and creator-content platforms
- Tied to Agent OS, Creative OS and the 7,000+ pieces of content a month: AI infrastructure, creator and influencer management, content compliance and measurement.
- Quick-commerce and marketplace operations
- Tied to quick commerce at about 10% of revenue and the fastest-growing channel: retail media, catalogue and availability tools, and logistics for dark-store replenishment.
- Supply chain and sourcing resilience
- Tied to the energy-cost and supply chain disruption challenges and the 12-warehouse network: demand forecasting, warehouse systems and alternative sourcing.
- Support for new brands and acquisitions
- Tied to the Reginald Men integration, the Honasa Health nutraceuticals subsidiary and the Fang stake: integration, e-commerce and compliance support for newly added brands and categories.
Tamtam's reading of the priorities and challenges above, not the company's own words.
Selling to companies like Honasa Consumer Ltd.?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companiesKey documents
Read in full by Tamtam; each summary links to the document itself.
- Honasa Consumer Limited Annual Report 2025-26
- Honasa Consumer Limited (NSE/BSE: HONASA; Mamaearth, The Derma Co, Aqualogica, Dr. Sheth's, BBLUNT, Staze 9to9, Reginald Men) describes itself as a "digital-first beauty and personal care company" serving consumers through a House of Brands: 7 brands across skincare, haircare, baby care and colour cosmetics.
- FY 25-26 (year to 31 March 2026): like-for-like revenue from operations ₹24,785 Mn, up 19.9% YoY; EBITDA ₹2,312 Mn (9.3% margin, up from ₹685 Mn); profit after tax ₹2,002 Mn (8.1% margin), the highest ever. Reported consolidated revenue from operations was ₹23,919.42 million, up 15.7%.
- Channel mix FY 25-26: 68% online, 32% offline; quick commerce is about 10% of revenue and the fastest-growing channel. Direct distribution now handles close to 80% of general trade billing (about 1.2 lakh outlets billed directly), up from roughly a third two years earlier; total reach is 2.7 lakh+ FMCG outlets.
- Strategy: seven focus categories (face cleansers, shampoos, sunscreens, moisturisers, face serums, lipsticks, baby care) now contribute about 80% of revenue and grew about 30%; close to 90% of brand investment goes to them.
- Mamaearth returned to growth (teens growth in FY 25-26); The Derma Co reached a ₹750 Cr annual recurring revenue run rate with a double-digit EBITDA profile; Reginald Men (men's grooming, acquired January 2026) passed ₹100 Cr ARR; a 25% stake in oral-care brand Fang was taken.
- FY 30-31 vision: become the fastest FMCG company in India to ₹5,500+ Cr revenue, Mamaearth at ₹2,000+ Cr, The Derma Co beyond ₹1,500 Cr, and a 15% EBITDA margin (500 bps more).
- Technology and AI: Agent OS with 30+ AI agents across 6 business functions, plus Tesseract (consumer simulation), FormulaOS (formulation) and Creative OS (content); described as built on data from more than 25 million consumers.
- First-ever dividend recommended: ₹3.00 per share (about ₹978.07 million, roughly 51.2% of standalone net profit after tax). Founders Varun Alagh (Chairman and CEO) and Ghazal Alagh (Chief Innovation Officer) lead the company; about 3,400 employees.
- Risks named: macro and Middle East energy volatility, consumer preference shifts, offline credit exposure, inventory, supply-chain disruption, data privacy (DPDP Act), counterfeiting and litigation.
- Q2 FY27 unaudited results: Outcome of Board Meeting, quarter and half year ended 30 September 2026
- Q2 FY27 (quarter ended 30 September 2026), unaudited consolidated results approved by the Board on 6 November 2026: revenue from operations ₹7,311.87 million versus ₹5,380.63 million in Q2 FY26 and ₹7,559.46 million in Q1 FY27.
- Profit after tax ₹732.48 million versus ₹392.27 million a year earlier (₹904.48 million in Q1 FY27); profit before tax ₹1,008.00 million versus ₹527.47 million.
- Six months ended 30 September 2026: revenue ₹14,871.33 million versus ₹11,333.17 million; profit after tax ₹1,636.96 million versus ₹805.52 million; diluted EPS ₹4.99.
- Standalone Q2 FY27 revenue ₹6,894.00 million and profit after tax ₹717.01 million; the Group still reports one segment (beauty and personal care, third-party manufactured).
- Operating cash flow for the six months ₹928.85 million versus ₹1.62 million; cash and cash equivalents ₹1,188.60 million; investments and deposits held (current investments ₹3,375.98 million).
- Inventories rose to ₹2,319.94 million (₹1,650.51 million at 31 March 2026); employee benefits expense for the quarter was ₹731.93 million.
- Corporate actions: ₹978.07 million dividend recognised after AGM approval on 28 September 2026; proposed 58% acquisition of Fluence Pharma called off on 25 August 2026; Honasa Health Private Limited incorporated 7 July 2026; a BBlunt group merger scheme approved by the subsidiaries' boards.
- UAE distributor case: Dubai Court of Cassation limited compensation to AED 1.75 million (Rs. 42.75 million); an arbitral award directs the distributor to pay the company AED 9.92 million.
- Honasa Consumer Q2 FY27 earnings call (JM Financial) with Varun Alagh
- Q2 FY27 call (6 November 2026, hosted by JM Financial): Varun Alagh calls it "the highest growth quarter since we went public"; net sales grew 36%, EBITDA doubled and the EBITDA margin was 12.7%.
- Gross margin held at 70% despite crude cost pressure, helped by price increases; underlying volume growth (UVG) was 31.3%.
- EBITDA drivers: channel and A&P efficiency gave roughly 250 to 270 basis points versus a year earlier, and operating leverage about 110 to 130 basis points.
- Focus categories are now 80%+ of revenue and grew 40%+; Honasa holds roughly 5% of a INR 50,000 crores focus-category market. E-commerce grew 20%+, general trade and modern trade 40%+.
- Mamaearth kept high-teens growth, with face wash market share up 140 bps and shampoo up 50 bps (NielsenIQ); available at 3.2 lakh outlets, up 26% in numeric distribution. Younger brands grew 45%+ (40%+ excluding The Derma Co).
- The Derma Co is the second INR 1,000 crore+ brand; offline market share about 1.2% in face wash with 65,000 outlets.
- Guidance: 15% EBITDA margin profile within four years; for the year, keeping the 150-200 bps plan is "conservative"; H2 margin expected around 12.5%; BBlunt hair colour portfolio growing more than 100%; a second-brand entry into hair colour is under consideration.
- Honasa Consumer Q4 and FY2026 earnings call (JM Financial) with Varun Alagh
- Q4 and FY 2026 call (21 May 2026, hosted by JM Financial): Varun Alagh reports a Q4 of FY 2026 with 28% like-for-like growth, EBITDA about two and a half times the prior-year quarter, INR 682 crores in quarterly revenue, 71.4% gross margin, EBITDA INR 77 crores (11.3%) and PAT INR 69 crores (10.2%).
- FY 2026: about 20% growth, EBITDA tripled to roughly a 9.3% margin, PAT above INR 200 crores; first-ever dividend INR 3 per share (about INR 98 crores, around 50% of PAT).
- Focus categories grew 35% in Q4 and their contribution rose 500 basis points in a year; they take 90%+ of investment.
- Mamaearth grew mid-teens in Q4 with a double-digit full year; management expects a double-digit CAGR for five years, with the brand in about 200,000 outlets and potentially 500,000 over three to five years.
- Reginald Men grew 100%+ and passed INR 100 crore ARR (sixth Honasa brand); The Derma Co ARR last disclosed at INR 750+ crores with double-digit EBITDA; Mamaearth and The Derma Co both EBITDA positive at double digits.
- Five-year plan: high-teens revenue CAGR and 500 bps EBITDA expansion (about 100 bps a year); calibrated price increases already taken for crude-linked cost inflation.
- Talent additions to build next-horizon businesses: a former cosmetics CEO, a nutraceuticals founder and a new-age operator; inside-out beauty (ingestibles) flagged as a future area.
Questions about Honasa Consumer Ltd.
What does Honasa Consumer do?
Honasa Consumer Limited is a listed Indian beauty and personal care company that owns Mamaearth, The Derma Co, Aqualogica, Dr. Sheth's, BBLUNT, Staze 9to9 and Reginald Men. It sells online (68% of revenue) and offline (32%).
What was Honasa's revenue in FY 25-26?
Like-for-like revenue from operations was ₹24,785 Mn, up 19.9%. Reported consolidated revenue from operations was ₹23,919.42 million, and profit after tax was ₹2,001.90 million.
Who owns Mamaearth?
Mamaearth is the founding brand of Honasa Consumer Limited, which is listed on NSE and BSE and led by co-founders Varun Alagh and Ghazal Alagh.
What is Honasa's strategy?
It concentrates about 90% of brand investment on seven focus categories, rebuilt general trade around direct distributors, and targets ₹5,500+ Cr revenue and a 15% EBITDA margin by FY 30-31.
How many people work at Honasa?
The Annual Report 2025-26 says the company has a team of over 3,400 people.
Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-19)